Xiang Fang

Xiang Fang serves as Professor of Neurology and Ambulatory Clinic Medical Director at the University of Texas Medical Branch (UTMB), with additional affiliation as a Member of the Mitchell Center for Neurodegenerative Diseases. His clinical and research activities focus on advancing neurological care through translational science and biomarker discovery.

Dr. Fang's research spans critical areas in neurology including neurodegenerative disease mechanisms, traumatic brain injury complications, and metabolic biomarker development for Alzheimer's disease. His work prominently features investigations into epoxyeicosatrienoic acids and soluble epoxide hydrolase pathways in neuroprotection, alongside clinical studies on Guillain-Barré Syndrome diagnostics and posttraumatic headache management.

Recent publications (2024-2025) demonstrate a concentrated focus on bridging laboratory findings with clinical applications, particularly in developing blood-based biomarkers for Alzheimer's diagnosis and optimizing pain management protocols for traumatic brain injury patients. His research integrates metabolomics, neuroimmunology, and translational stem cell approaches to address unmet needs in neurological disorders.

Scientific Awards:
No scientific awards were documented in the provided source material.

Dr. Fang has secured significant research funding as Principal Investigator on two major projects: (1) 'Role of Neuroprotective Indoles in Delaying the Onset of Cognitive Decline' (National Institute on Aging, 2021-2025) investigating cognitive preservation strategies, and (2) 'Acetylcholine receptor binding B cells as biomarker for myasthenia gravis' (Immune Globe Biotech, LLC, 2017-2022) developing novel diagnostic tools for autoimmune neurological conditions.

As a core member of UTMB's Mitchell Center for Neurodegenerative Diseases, Dr. Fang contributes to multidisciplinary research initiatives targeting Alzheimer's, Parkinson's, and related dementias. His laboratory and clinical teams integrate metabolomics, neuroimmunology, and clinical neurology to develop innovative diagnostic and therapeutic approaches for neurodegenerative conditions.